BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 10714213)

  • 1. [Loss of junB expression causes a myeloproliferative syndrome resembling chronic myeloid leukemia].
    Jochum W; Passegue E; Wagner EF
    Verh Dtsch Ges Pathol; 1999; 83():216-7. PubMed ID: 10714213
    [TBL] [Abstract][Full Text] [Related]  

  • 2. JunB deficiency leads to a myeloproliferative disorder arising from hematopoietic stem cells.
    Passegué E; Wagner EF; Weissman IL
    Cell; 2004 Oct; 119(3):431-43. PubMed ID: 15507213
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lhx2 expression in hematopoietic progenitor/stem cells in vivo causes a chronic myeloproliferative disorder and altered globin expression.
    Richter K; Pinto do O P; Hägglund AC; Wahlin A; Carlsson L
    Haematologica; 2003 Dec; 88(12):1336-47. PubMed ID: 14687986
    [TBL] [Abstract][Full Text] [Related]  

  • 4. c-Jun and JunB are essential for hypoglycemia-mediated VEGF induction.
    Textor B; Sator-Schmitt M; Richter KH; Angel P; Schorpp-Kistner M
    Ann N Y Acad Sci; 2006 Dec; 1091():310-8. PubMed ID: 17341624
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
    Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
    J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic myeloid leukemia with increased granulocyte progenitors in mice lacking junB expression in the myeloid lineage.
    Passegué E; Jochum W; Schorpp-Kistner M; Möhle-Steinlein U; Wagner EF
    Cell; 2001 Jan; 104(1):21-32. PubMed ID: 11163237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Kinetics of proliferation, differentiation and transcription of genes regulating apoptosis in cultured human BCR/ABL+ Ph+-cells].
    Akhlynina TV; Gerasimova LP; Sarkisian GP; Borovkova TV; Dukhovenskaia EA; Manakova TE; Naĭdenova NM; Timofeev AM; Grineva NI
    Tsitologiia; 2007; 49(10):889-900. PubMed ID: 18074781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bcr-Abl has a greater intrinsic capacity than v-Abl to induce the neoplastic expansion of myeloid cells.
    Gross AW; Ren R
    Oncogene; 2000 Dec; 19(54):6286-96. PubMed ID: 11175343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. JunB can substitute for Jun in mouse development and cell proliferation.
    Passegué E; Jochum W; Behrens A; Ricci R; Wagner EF
    Nat Genet; 2002 Feb; 30(2):158-66. PubMed ID: 11818961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. JunB is a gatekeeper for B-lymphoid leukemia.
    Ott RG; Simma O; Kollmann K; Weisz E; Zebedin EM; Schorpp-Kistner M; Heller G; Zöchbauer S; Wagner EF; Freissmuth M; Sexl V
    Oncogene; 2007 Jul; 26(33):4863-71. PubMed ID: 17297445
    [TBL] [Abstract][Full Text] [Related]  

  • 11. c-Jun blocks cell differentiation but not growth inhibition or apoptosis of chronic myelogenous leukemia cells induced by STI571 and by histone deacetylase inhibitors.
    Huang HM; Liu JC
    J Cell Physiol; 2009 Mar; 218(3):568-74. PubMed ID: 19006173
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DNA methylation does not regulate JUNB expression in CML: comment on "Downregulation of JUNB mRNA expression in advanced phase chronic myelogenous leukemia" by Hoshino et al. [Leuk. Res. 33 (2009) 1361-1366].
    Strathdee G; Ferguson S; Sim A; Brown R
    Leuk Res; 2010 May; 34(5):685-6. PubMed ID: 20006998
    [No Abstract]   [Full Text] [Related]  

  • 13. [Molecular biologic study in chronic myelogenous leukemia and its related disorders].
    Ohyashiki JH; Ohyashiki K; Toyama K
    Rinsho Ketsueki; 1988 Jul; 29(7):1010-7. PubMed ID: 3184468
    [No Abstract]   [Full Text] [Related]  

  • 14. JunB gene expression is inactivated by methylation in chronic myeloid leukemia.
    Yang MY; Liu TC; Chang JG; Lin PM; Lin SF
    Blood; 2003 Apr; 101(8):3205-11. PubMed ID: 12506033
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of SPA-1 in phenotypes of chronic myelogenous leukemia induced by BCR-ABL-expressing hematopoietic progenitors in a mouse model.
    Kometani K; Aoki M; Kawamata S; Shinozuka Y; Era T; Taniwaki M; Hattori M; Minato N
    Cancer Res; 2006 Oct; 66(20):9967-76. PubMed ID: 17047059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Induction of the AP-1 members c-Jun and JunB by TGF-beta/Smad suppresses early Smad-driven gene activation.
    Verrecchia F; Tacheau C; Schorpp-Kistner M; Angel P; Mauviel A
    Oncogene; 2001 Apr; 20(18):2205-11. PubMed ID: 11402315
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PU.1 and Junb: suppressing the formation of acute myeloid leukemia stem cells.
    Somervaille TC; Cleary ML
    Cancer Cell; 2006 Dec; 10(6):456-7. PubMed ID: 17157786
    [TBL] [Abstract][Full Text] [Related]  

  • 18. C/EBPdelta expression in a BCR-ABL-positive cell line induces growth arrest and myeloid differentiation.
    Gery S; Tanosaki S; Hofmann WK; Koppel A; Koeffler HP
    Oncogene; 2005 Feb; 24(9):1589-97. PubMed ID: 15674331
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The fusion protein AML1-ETO in acute myeloid leukemia with translocation t(8;21) induces c-jun protein expression via the proximal AP-1 site of the c-jun promoter in an indirect, JNK-dependent manner.
    Elsässer A; Franzen M; Kohlmann A; Weisser M; Schnittger S; Schoch C; Reddy VA; Burel S; Zhang DE; Ueffing M; Tenen DG; Hiddemann W; Behre G
    Oncogene; 2003 Aug; 22(36):5646-57. PubMed ID: 12944913
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.